Hints and tips:
...He also has served on the board of Genzyme, the biotech company sold to Sanofi-Aventis this year for more than $20bn....
...Aventis Pharma seals deal to buy Universal Medicare Aventis Pharma, a part of French drug maker Sanofi has entered into a definitive agreement to acquire Universal Medicare’s marketing and distribution business...
...In a research note on Monday, Cowen argued that a number of the large pharmaceutical groups, led by Eli Lilly, Sanofi-Aventis and Pfizer, would be worth more if they divested separable business units, which...
...From Market Watch: French pharmaceuticals major Sanofi-Aventis SA confirmed Wednesday it has struck a deal to buy U.S. peer Genzyme Corp....
...Sanofi-Aventis has continued aggressively to acquire others, including ultimately winning support for the takeover of US group Genzyme after raising its bid above $20bn....
...Diabetes medications still make up about 17 per cent of Lilly’s $22bn revenues, but in recent years it has lost ground to rivals such as Merck and Sanofi-Aventis....
...Sanofi-Aventis stepped up its pursuit of Genzyme on Sunday, outlining publicly its interest in a takeover deal as it inched closer to making a hostile offer for the US biotech company....
...of some of sanofi-aventis’ Prescription Medicines to Over-the-Counter Products – Chattem Management to Lead the U.S....
...In pharmaceuticals, the government engineered the merger between Sanofi and Aventis to create a new champion rather than allow the Swiss Novartis to swallow it up....
...Total’s fourth-quarter adjusted net income – the number most watched by analysts which strips out gains from changes in the value of fuel inventories, one-off items and the value of Total’s stake in Sanofi-Aventis...
...The bodies collaborating on the RV144 trial in Thailand – including the US Army and National Institutes of Health, the Thai health ministry and Sanofi Aventis, the giant French drug company – could hardly...
...A study by a British medical journal reported that a blood-thinning pill developed by the company worked better than Plavix, a rival drug made by Sanofi-Aventis....
...The World Health Organisation on Monday said that leading vaccine producers including Novartis, GlaxoSmithKline and Sanofi-Aventis had requested “wild type virus” samples of the A (H1N1) virus....
...Germans recall with bitterness the government intervention that ensured French control of the Franco-German pharmaceutical group Aventis, today known as Sanofi-Aventis....
...Then again, now that the Dutch group has flagged its interest in a takeover, Sanofi-Aventis and its rivals may come back with counter offers....
...Bernstein saw Bristol-Myers Squibb, GlaxoSmithKline and Sanofi Aventis among potential buyers of the franchise....
...His appointment comes as GlaxoSmithKline also seeks a new US head of operations, following the recent departure of Chris Viehbacher, who takes over as chief executive of Sanofi-Aventis of France at the start...
...Swiss drugmaker Novartis gained 23.7 per cent to SFr59.50 while in France, Sanofi-Aventis climbed 17.2 per cent to €44.44. Germany’s BMW was boosted by an upgrade from Goldman Sachs....
...Mr Buffett also added to his positions in Ingersoll-Rand, a maker of refrigeration gear, and Sanofi Aventis, the French drugmaker....
...Shares in Bristol-Myers Squibb fell 3.3 per cent to $27.59 after reports of a break-down in the merger talks with Sanofi-Aventis ....
...Sanofi-Aventis, the pharmaceutical group formed when Sanofi Synthelabo merged with Aventis in 2004 after the French government intervened to warn off Novartis, bought a 19.6 per cent stake from Warburg Pincus...
...Our preferred stock picks are Novartis and Sanofi-Aventis.” Sanofi-Aventis climbed 2.5 per cent to €72.65 while Novartis added 1.1 per cent to €71.35....
...But Friday’s sale comes after the Kuwait Petroleum Corporation (KPC) last year reduced its 13.5 per cent stake in Aventis following the takeover by Franco-German group Sanofi-Synthelabo....
...Sanofi-Aventis faces its own court battle over generic competition for its blood-thinning drug Plavix....
...Novartis fell 1.4 per cent to SFr69.10 amid talk that it was emerging as the leading contender but others rumoured to be interested included Roche , 1.8 per cent higher at SFr224.0, Sanofi-Aventis , 0ff...
International Edition